Aifred Health is proud to bring together a diverse and interdisciplinary team of
clinicians, neuroscientists, computer scientists and researchers with lived experience to tackle
current challenges in the field of mental health.
Monique Champagne, MSc, is the Vice President of Clinical Research and
Regulatory Affairs at Aifred Health. Ms. Champagne has more than 30 years of experience in
clinical research, drug development and regulatory affairs, gained in the pharmaceutical,
biotechnology and contract industries. A leader and creative manager, she has extensive
practical experience and expertise in the early phases of product development, clinical
development in various therapeutic areas, clinical operations management, regulatory affairs and
strategic planning, business process integration and improvement, as well as in international
project management and business partner relations. Ms. Champagne's previous executive positions
include President and Chief Executive Officer of Ilkos Therapeutics Inc. and Vice President,
Clinical Research and Regulatory Affairs at Telesta Therapeutics.
A seasoned Finance professional with close to two decades of experience working
in private and public companies, specifically in market-leading software and technology
businesses the last 6 years. Joe has a strong background in operations, sales support, strategic
sourcing, contracting and financial modelling. He creates, manages, and maintains the budget,
forecast and various key metrics, while keeping security and confidentiality top of mind. He is
a CPA and holds a Bachelor Degree in Accountancy from Concordia University. Serves on the Board
of Directors of the Fondation Marie-Louise Clarac, and is actively involved within his community
as well as his regional soccer club.
Dr. David Benrimoh
As CSO of Aifred Health, David provides strategic scientific direction and acts
as a bridge between the machine learning and clinical team. He is also a Psychiatry Resident and
Researcher at McGill University. He obtained his MD.,CM at McGill and an MSc
(Neuroscience-Distinction) from University College London.
Robert Fratila is a Co-Founder and VP of AI at Aifred Health. Trained in computer
science and biology, his passion for combining medicine and AI throughout his work and research
has grown extraordinarily. As a software developer at the Montreal Neurological Institute, he
worked on integrating state-of-the-art deep learning techniques in the healthcare industry,
specifically brain imaging. This has given him valuable experience in finding efficient
solutions to complex problems. As a cofounder of Aifred Health, he managed machine learning
research and product engineering teams, producing world-leading software and extremely promising
results for mental health care. He has also given many invited talks and workshops about his
work and research at a variety of events, including the Canadian University Software Engineering
Conference (CUSEC) and the Sixth Biennial Conference on Resting State and Brain Connectivity. He
is committed to spreading knowledge and demystifying the wonderful field of machine learning.
Sonia holds a BSc in Honours Neuroscience from McGill University, where she
founded the student neurotechnology group that eventually gave rise to Aifred Health. As a
lifelong entrepreneur, Sonia appreciates the value of strategic business leadership to effect
change in clinical practice. She continuously strives to help enhance the interface between
leading research and neurological health care.
Kelly Perlman, a graduate neuroscience student in McGill’s integrated program in
neuroscience, is a co-founder of Aifred Health. She is also the director of research and has the
primary goal of ensuring that every step in the development of the product is firmly grounded in
science. Her responsibilities include conducting systematic reviews of relevant scientific
literature along with the research team, assessing the feasibility of biomarker implementation,
and planning for future clinical trials. She has conducted research in laboratories studying
neuroimaging and neuroimmunology. Kelly is immensely passionate about all things science and she
is dedicated to ensuring that Aifred Health stays at the forefront of biomedical innovation.
Caitrin holds a BA&Sc in Cognitive Science and an MSc in Computer Science, both
from McGill University. She has extensive expertise in applying computational techniques to new
domains with complex human data, including work in software development for mental health, and
as a researcher in computational social science. She is thrilled to put this knowledge to work
and lead Aifred’s development efforts to produce a revolutionary evidence-based AI tool.
Charlie Gower has 20 years of years of product design and research experience in
digital and physical domains both at startups he founded and at multinationals. With tenure in
leadership roles at agencies, startups, and working in house across Europe and the US, Charlie
brings experience in healthcare from the consumer side as well as the hospital side. Having
invented services for 100M Chinese teenagers, to executive tools used by 10, he's excited to be
on the Aifred journey.
Janaka is a seasoned engineer and product owner leading the Aifred product
A seasoned business leader with more than 15 years senior management experience,
Ms. Massingham has held senior roles at management consultancy Kaiser Associates, Cadbury and
Novartis. Ms. Massingham also brings Canadian healthcare startup experience to the Aifred team,
having co-founded Canadian pharmaceutical startup TeOra Health, acquired by Aequus
Pharmaceuticals in 2015. Most recently, she served as VP Marketing for Aequus, prior to joining
Aifred Health. Based in Montréal since 2013, Ms. Massingham holds a Bachelor of Science from the
University of Leeds and a Masters in International Management from King’s College, London.
Donald is an experienced life sciences executive, entrepreneur and director with
significant experience raising capital for private and public technology companies. Most
recently, he was President and CEO of Montreal-based NEOMED Institute, a position he held until
the successful closing of a merger with Vancouver-based CDRD. He has held multiple executive
positions as CEO, COO and CFO of private and public life science and technology companies and
began his business career as a commercial, corporate and investment banker working across a
variety of industry verticals. Mr. Olds has significant corporate governance experience as a
board member and chair of both for profit and not for profit organizations. He is currently lead
director at Goodfood Markets (TSX:FOOD), director of Acasti Pharma (NASDAQ:ACST), past Chair of
Oxfam Quebec and director of private Presagia Corp. He holds an MBA and M.Sc. from McGill